PMHS Polomar Health Services, Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$0.12

Period return

-0.68 (-85.25%)

Volume

2026-07-20O $0.12 H $0.12 L $0.12 C $0.12MA5 $0.12MA20 $0.12MA60 $0.16MA120 $0.21

6M · 123 barsYahoo Finance · USD2026-01-22 → 2026-07-20

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2024. 09. 30.Medium2 years ago
2025년 3분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2024. 06. 30.Medium2 years ago
2025년 2분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2024. 03. 31.Medium2 years ago
2025년 1분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2023. 09. 30.Medium3 years ago
2024년 3분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2022. 09. 30.Medium4 years ago
2023년 3분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

Sector: Healthcare
Industry: Pharmaceutical Retailers
HQ: Los Angeles, CA, United States
Fiscal year end: —
Employees: 6
IPO date: —

View details →

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
FY2025 Q3	2024. 09. 30.	Time TBD	—	$-0.02	—	—	$37.95K	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$-0.01	—	—	$28.11K	Reported
FY2025 Q1	2024. 03. 31.	Time TBD	—	$-0.01	—	—	$13.61K	Reported
FY2024 Q3	2023. 09. 30.	Time TBD	—	$-0.01	—	—	$24.56K	Reported

Polomar Health Services, Inc.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats